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No-shows to primary care appointments:
subsequent acute care utilization among diabetic
patients
Lynn A Nuti1, Mark Lawley2, Ayten Turkcan3, Zhiyi Tian4, Lingsong Zhang4,5, Karen Chang1, Deanna R Willis6
and Laura P Sands7*
Abstract
Background: Patients who no-show to primary care appointments interrupt clinicians’ efforts to provide continuity
of care. Prior literature reveals no-shows among diabetic patients are common. The purpose of this study is to
assess whether no-shows to primary care appointments are associated with increased risk of future emergency
department (ED) visits or hospital admissions among diabetics.
Methods: A prospective cohort study was conducted using data from 8,787 adult diabetic patients attending
outpatient clinics associated with a medical center in Indiana. The outcomes examined were hospital admissions or
ED visits in the 6 months (182 days) following the patient’s last scheduled primary care appointment. The
Andersen-Gill extension of the Cox proportional hazard model was used to assess risk separately for hospital
admissions and ED visits. Adjustment was made for variables associated with no-show status and acute care
utilization such as gender, age, race, insurance and co-morbid status. The interaction between utilization of the
acute care service in the six months prior to the appointment and no-show was computed for each model.
Results: The six-month rate of hospital admissions following the last scheduled primary care appointment was 0.22
(s.d. = 0.83) for no-shows and 0.14 (s.d. = 0.63) for those who attended (p< 0.0001). No-show was associated with
greater risk for hospitalization only among diabetics with a hospital admission in the prior six months. Among
diabetic patients with a prior hospital admission, those who no-showed were at 60% greater risk for subsequent
hospital admission (HR = 1.60, CI = 1.17–2.18) than those who attended their appointment. The six-month rate of ED
visits following the last scheduled primary care appointment was 0.56 (s.d. = 1.48) for no-shows and 0.38 (s.d. = 1.05)
for those who attended (p< 0.0001); after adjustment for covariates, no-show status was not significantly related to
subsequent ED utilization.
Conclusions: No-show to a primary care appointment is associated with increased risk for hospital admission
among diabetics recently hospitalized.
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Background
Diabetes is a rising health care concern as its prevalence
continues to grow in the United States. Diabetes mellitus
was ranked as the seventh leading cause of death in
2009 [1]. In 2007, $218 billion was spent in total esti-
mated costs for diabetes, with $153 billion due to med-
ical costs and $65 billion due to reduced productivity
[2]. There were nearly 125 million visits to Emergency
Departments (ED) in 2008 and over 98.5 million were
for adults; the most frequent reasons for adult ED visits
revealed that diabetes mellitus without complications
ranked third (9.3%) of all ED visits [3]. In 2007, an esti-
mated $3.87 billion was attributed to emergency depart-
ment costs for diabetes [4]. In 2008 over 7.7 million
hospital admissions and $83 billion in costs were attrib-
uted to diabetes [5].
Complications and costs from diabetes can be reduced
by consistent and effective disease management [6]. For
effective diabetes management, national clinical practice
guidelines recommend patients visit their healthcare
provider every 3 to 6 months [6]. For a majority of
patients, the primary care provider (PCP) manages their
diabetic care and patients whose diabetes is managed by
a specialist rely upon their PCP for supervising their
complete care [7]. Promotion of diabetes management
is, in part, dependent upon patient adherence with med-
ical appointments with their PCP. When a patient
misses an appointment without canceling a no-show
occurs. No-shows to primary care appointments can
interrupt continuity of care and effective disease man-
agement. Studies report that no-show rates for patients
with diabetes range from 4% to 40% [8-13]. In addition,
literature indicates that diabetic patients with higher no-
show rates have higher glycosylated hemoglobin (A1C)
levels and therefore, poorer glycemic control than those
patients that attended appointments [8,11,13-16].
Diabetes is one of several chronic conditions that are
considered ambulatory care sensitive conditions. Ambu-
latory care sensitive conditions are those that if treated
in a timely and effective manner in the ambulatory care
setting should not require acute care services [17]. Use
of acute care services for ambulatory care sensitive con-
ditions is considered evidence of a breakdown in out-
patient care [18]. A study of hospital claims data from a
nationally representative sample of Medicare recipients
with diabetes revealed that seven percent of hospitali-
zations were for diagnoses that have been character-
ized as ambulatory care sensitive conditions [18].
Similarly, four percent of ED visits are for diagnoses
associated with ambulatory care sensitive conditions
[19]. To our knowledge, no prior studies have assessed
whether no-shows to primary care appointments are
associated with increased risk of subsequent ED visits
or hospital admissions.
The hypothesis underlying this study is that diabetic
patients who no-show to primary care appointments have
higher risk for subsequent ED visits and hospital admis-
sions than those who do not miss their scheduled primary
care visits. A secondary hypothesis is that compared to
patients who attended their last appointment, patients
who no-show would be more likely to have admission
diagnoses for their subsequent acute care admissions that
are sensitive to diabetes-associated ambulatory care.
Methods
Study Design
A prospective cohort study was conducted to examine
ED visits and hospital admissions six months follow-
ing the last scheduled primary care appointment. This
study was approved by the Institutional Review Boards
of Indiana University School of Medicine and Purdue
University.
Patient participants
Patients attending outpatient clinics associated with an
academic medical center in Indiana were included in the
sample. The sample consisted of 9,411 patients with two
or more billing records with International Classification
of Diseases (ICD-9) diabetes codes (250.xx, 357.2, 362.0,
and 366.41). Only adults, 18 years of age or older, with
the above ICD-9 codes were included in the sample
(N= 9,393). Diabetic patients with one or more sched-
uled appointments within the last 2 years (N = 9,387)
were included if they had clinical information in the
medical records database one year prior to and one year
after the last scheduled primary care appointment
(N= 8,787).
Data sources
Patient demographics, diagnoses, appointment history
and characteristics, insurance and billing data were
retrieved from scheduling and billing data collected dur-
ing primary care visits occurring between January 2005
and June 2007. Hospital admission dates, emergency
department visit dates, and primary diagnoses from
January 2005 through to December 2007 were retrieved
from the Regenstrief Medical Records System (RMRS)
which covers over 1.5 million patients in the greater
Indianapolis area. RMRS is utilized by three hospital
systems associated with the medical clinics incorpo-
rated in this study, including the largest hospital system in
Indianapolis.
Independent variables
In this study no-show status was defined as patients who
did not show for their last scheduled primary care ap-
pointment. Patients who attended their last primary care
appointment comprised the referent group.
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Covariates
Gender was included with female as the referent group.
Age was categorized into four ranges: 18–30 years,
31–45 years, 46–70 years, and≥ 70 years with 18–30 years
of age designated as the referent group. Race was classified
as black, white, other, and unknown with white as the
referent group. Patient insurance coverage was categor-
ized as Medicaid, Medicare, self-pay, county tax-funded
program, and commercial insurance with commercial as
the referent group. Cardiovascular complications from
diabetes included atherosclerosis, angina pectoris, myocar-
dial infarction, heart failure, aortic aneurysm/dissection,
other ischemic heart disease (IHD) and other chronic IHD
(ICD-9 codes, respectively: 440.xx, 413, 410, 428, 441, 411,
and 414) [20]. Nephropathy complications from diabetes
included diabetic nephropathy, acute glomerulonephritis,
nephritic syndrome, hypertension nephrosis, chronic
glomerulonephritis, nephritis/nephropathy, chronic renal
failure, renal failure not otherwise specified (NOS), and
renal insufficiency (ICD-9 codes, respectively: 250.4, 580,
581, 581.81,582, 583, 585, 586, 593.9) [20]. A Charlson
co-morbidity score was computed to describe the number
and severity of co-morbidities [21]. To compute this
score a weight was applied to each co-morbidity, weights
are founded on one-year mortality, and the weighted
co-morbidities are totaled for each patient. Charlson
co-morbidity scores can range from 0 to 27 with most
patients falling below 3. ED visits and hospital admissions
in the six months prior to the last scheduled primary care
appointment were included, with the referent groups
being no ED or hospital admissions in the six months
prior, respectively.
Dependent variables
In one model the dependent variable was time to ED
visits within six months (182 days) following the
patient’s last scheduled primary care appointment. In the
other model the dependent variable was time to hospital
admissions within six months after the patient’s last
scheduled primary care appointment.
In an analysis addressing the secondary hypothesis, the
dependent variables was whether or not the primary
diagnosis the first hospital admission was for diabetes
diagnoses described in prior publications as potentially
preventable. For example, diagnoses included diabetes
without mention of complication and diabetes with men-
tion of ketoacidosis, hyperglycemia, hypoglcemia, coma,
or an unspecified complication (ICD-9=250.0–250.3,
250.8–250.10, 250.12, 250.13, 250.20, 250.22, 250.23,
250.30, 250.32, 250.33, 250.90, 250.92, or 250.93) [19].
Statistical analyses
Data analyses were conducted using SAS 9.2. Poisson re-
gression models were computed to determine the bivariate
association between each independent variable and each
dependent variable. Independent variables with a p-value
of 0.20 or less were included in the multivariable models.
The Andersen-Gill formulation of the Cox proportional
hazard model was used to model the association between
no-show at the last scheduled primary care appointment
and ED or hospital utilization after adjustment for covari-
ates related to ED or hospital utilization [22]. Unlike
the traditional Cox proportional hazard models, the
Andersen-Gill model accommodates the dependence be-
tween multiple event times that occur when a subject has
more than one event (e.g. more than one hospital admis-
sion within six months) [22]. There are three different sce-
narios for calculating time to event (ED visits or hospital
admissions). In the first scenario, there is no event and the
time interval is defined as six months following the last
scheduled primary care appointment. In the second sce-
nario, there is one event within the 182 days following the
last scheduled appointment. In this scenario the time
interval is defined as days following the last scheduled
primary care appointment up to and including the
visit/admission date. In the third scenario, there are
multiple events and the first time interval is defined
as in scenario two above with subsequent time inter-
vals beginning with the previous discharge date and
extending to the date of the next visit/admission or
the end of the observed interval. Intervals are discon-
tinuous for hospital events because when subjects are
hospitalized, they are not at risk of another admission
until they have been discharged. A sandwich variance
estimator was used to adjust the standard error esti-
mates to account for the dependence among the repeated
events within one subject (e.g. multiple ED visits). Each
model included the interaction between utilization of the
acute care service in the prior six months and no-show
status.
In analyses to address whether the acute care admis-
sion was for an ambulatory care sensitive condition, a
chi-square test was computed to examine the association
between no-show status at the last scheduled appoint-
ment and whether or not the primary diagnosis was
among the set considered to be a potentially preventable
diabetes related diagnosis.
Results
Among the 8,787 patients included in this study, 1421
(16.2%) did not show up to their last scheduled medical
appointment. Table 1 reveals that the six-month rate of
ED visits following the last scheduled primary care
appointment was 0.56 (s.d. = 1.48) for no-shows and 0.38
(s.d. = 1.05) those who attended (p < 0.0001). The six-
month rate of hospital admissions following the last
scheduled primary care appointment was 0.22 (s.d. = 0.83)
for no-shows and 0.14 (s.d. = 0.63) for those who attended
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(p < 0.0001). Figure 1 shows that no-show status is asso-
ciated with time to utilization of acute care services.
Patient characteristics that were significantly associated
with the greater risk for subsequent acute care utilization
(Table 1) included: female gender; aged 45 or younger;
black race; non-commercial insurance; cardiovascular co-
morbidity; nephropathy co-morbidity; higher Charlson
score; having an ED visit or hospital admission within six
months prior to the last scheduled primary care appoint-
ment, and no-show at the last scheduled primary care
appointment. Table 2 reveals that patient characteristics
associated with no-show to the last appointment include
younger age, non-white race, Medicaid insurance or self-
pay, and acute care utilization in the prior six months.
Results from the Andersen Gill multiplicative hazard
model revealed that no-show status was not associated
with subsequent ED use after adjustment for covariates
related to no-show status and ED utilization. Results
from the Andersen Gill model revealed that the inter-
action between prior hospital admission and no-show on
Table 1 Bivariate analysis on ED visits or hospital admissions within 6 months after last scheduled primary care
appointment
N=8787 N (%) ED visits in P value* Hospital admissions P value*
6 months in 6 months
mean (SD) mean (SD)
Gender Female 5268(59.9%) 0.43(1.16) <0.0001 0.16(0.75) 0.03
Male 3519(40.1%) 0.36(1.09) - 0.14(0.52) -
Age 18–30 314(3.6%) 0.68(1.42) <0.0001 0.13(0.49) 0.005
31–45 1676(19.1%) 0.56(1.56) <0.0001 0.12(0.48) <0.0001
46–70 5695(64.8%) 0.36(1.01) 0.28 0.15(0.73) <0.0001
≥ 70 1102(12.5%) 0.33(0.80) - 0.21(0.62) -
Race Black 3655(41.6%) 0.50(1.22) <0.0001 0.17(0.65) 0.01
Other 782(8.9%) 0.28(0.98) 0.001 0.13(1.21) 0.11
Unknown 383(4.4%) 0.18(0.56) <0.0001 0.08(0.45) 0.0004
White 3967(45.2%) 0.36(1.11) - 0.15(0.54) -
Insurance Medicaid 779(8.9%) 0.74(1.88) <0.0001 0.27(1.00) <0.0001
Medicare 2746(31.3%) 0.41(1.03) <0.0001 0.21(0.63) <0.0001
Self-pay 471(5.4%) 0.47(1.49) <0.0001 0.11(0.39) 0.04
County 2792(31.8%) 0.46(1.16) <0.0001 0.13(0.78) <0.0001
Tax-funded
Program
Commercial Insurance 1999(22.8%) 0.17(0.56) - 0.08(0.35) -
Cardiovascular Yes 1313(14.9%) 0.53(1.30) <0.0001 0.32(0.74) <0.0001
No 7474(85.1%) 0.38(1.10) - 0.13(0.65) -
Nephropathy Yes 526(6.0%) 0.63(1.43) <0.0001 0.46(1.66) <0.0001
No 8261(94.0%) 0.39(1.11) - 0.13(0.54) -
Charlson Score 1 6495(73.9%) 0.34(1.00) <0.0001 0.10(0.50) <0.0001
2 1497(17.0%) 0.53(1.46) <0.0001 0.20(0.61) <0.0001
3+ 795(9.1%) 0.68(1.37) - 0.47(1.44) -
ED visits within 6 months prior to last
scheduled primary care appointment
Yes 2584(29.4%) 0.86(1.75) <0.0001 -+ -
No 6203(70.6%) 0.21(0.65) - -+ -
Hospital admissions within 6 months prior
to last scheduled primary care appointment
Yes 1081(12.3%) -+ - 0.58(1.52) <0.0001
No 7706(87.7%) -+ - 0.09(0.39) -
No-show at last scheduled primary care
appointment
Yes 1421(16.2%) 0.56(1.48) <0.0001 0.22(0.83) <0.0001
No 7366(83.8%) 0.38(1.05) - 0.14(0.63) -
*P values are from Poisson regression. + Bivariate associations for variables that were not to be included in the multivariable analyses were not computed.
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subsequent hospital admissions was significant (p=0.0017).
Table 3 shows that compared to patients without a prior
hospital admission and attended their appointment, those
who had a prior admission and no-showed had the highest
risk for subsequent hospitalization (HR=6.13; CI= 4.60–
8.18), followed by those with a prior hospitalization, but
attended their last appointment (HR=3.84, CI=3.01–4.90).
Among the subgroup of diabetic patients who had a prior
hospital admission, those who no-showed were at 60%
greater risk for subsequent hospital admission (HR=1.60,
CI= 1.17-2.18) than those who attended their appointment.
No-shows who did not have a prior admission were not at
greater risk than patients without a prior hospital admission
and attended their appointment (HR=0.83, CI =0.63–
1.09). No-shows were significantly more likely to have hos-
pital admission for diabetes diagnoses described in prior
publications as potentially preventable compared to those
that attended their appointment (Table 4: 13.64% versus
4.37% respectively; Chi-square= 20.47; dF=1; p<=0.001).
Discussion
This study provides evidence that among diabetic
patients with a recent history of a hospital admission,
those that no-show to their PCP appointment are at sig-
nificantly greater risk for subsequent ED visits and hos-
pital admissions than those that attended their PCP
appointment. This finding confirms and extends prior
research that describes the potential health conse-
quences of patients not showing to their primary care
appointment. Prior studies reported that those patients
that missed their primary care appointments had poorer
glycemic control [8,11,13-16,23]. However, prior studies
have not reported that patients with diabetes who miss
their medical appointments are at increased risk for sub-
sequent hospital admissions. No-shows can disrupt con-
tinuity of care which is vital for maintenance and
improvement of diabetics’ health status >[24]. Results
from this study provide evidence of the need for pro-
active interventions that significantly reduce no-show
rates.
Acute care utilization may reflect a substitution of
acute care services for primary care services for some
patients [25]. A recent study revealed patients that no-
showed to their primary care appointments were signifi-
cantly more likely to receive their diabetes care using
same-day appointments [23]. This suggests that patients
that no-show may be more reactive than proactive in
their approach to managing their diabetes [23]. A react-
ive approach is particularly problematic for patients with
a recent history of hospitalization as it does not allow
the opportunity for continuous treatment and moni-
toring of the condition that precipitated the hospital
admission. This study provides indirect evidence that
interruptions in primary care can contribute to poor
management of diabetes because, compared to patients
who attended their appointment, patients that no-
showed were more likely to be admitted for diabetes
diagnoses described in prior publications as potentially
preventable.
Clinic-based interventions to reduce no-shows include
telephone reminders which only modestly decrease
no-show rate [26-28] and open access scheduling [29].
Although open access scheduling significantly reduces
no-show rates, it does not adequately support chronic
Figure 1 ED visits and Hospital admissions for diabetic patients within 6 months following the last scheduled primary care
appointment.
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care because the patient has to initiate the next appoint-
ment; that is, the patient has to remember to call for an
appointment at the appropriate time as specified in clin-
ical practice guidelines. Future clinic-based interventions
to reduce no-show rates should consider additional
modifiable clinic procedures that influence no-show rate.
For example, our prior work demonstrated that patients
who schedule their visit more than two weeks in advance
are twice as likely to no-show to their next scheduled ap-
pointment [30]. An automated system that reminds
patients to make appointments within weeks of their next
needed appointment may be effective in reducing no-
show rate.
Future development of clinic interventions to reduce
no-show rate should consider costs of no-shows com-
pared to costs associated with developing a multi-
factorial approach that includes proactive planning,
scheduling, reminding and rescheduling when patients
miss an appointment. Costs of no-show extend beyond
lost revenue for the missed appointments [30]. This
study provides evidence that costs of no-show should
also include downstream costs associated with the cost
of acute care that occurs after no-shows. An average
charge for a hospital stay for a diabetic is nearly $11,000
[3]. The 1421 no-shows in this study experienced an ex-
cess of 95 hospital admissions compared to subjects that
Table 2 Bivariate analysis on no-show status and other covariates
N=8787 N (%) No-show to last P value*
scheduled appointment
N (%)
Gender Female 5268(59.9%) 827(15.7%) 0.14
Male 3519(40.1%) 594(16.9%)
Age 18–30 314(3.6%) 87(27.7%) <0.0001
31–45 1676(19.1%) 359(21.4%)
46–70 5695(64.8%) 837(14.7%)
≥ 71 1102(12.5%) 138(12.5%)










Commercial Insurance 1999(22.8%) 254(12.7%)
Cardiovascular Yes 1313(14.9%) 200(15.2%) 0.32
No 7474(85.1%) 1221(16.3%)
Nephropathy Yes 526(6.0%) 83(15.8%) 0.80
No 8261(94.0%) 1338(16.2%)
Charlson Score 1 6495(73.9%) 1064(16.4%) 0.38
2 1497(17.0%) 242(16.2%)
3+ 795(9.1%) 115(14.5%)
ED visits within 6 months prior to last
scheduled primary care appointment
Yes 2584(29.4%) 553(21.4%) <0.0001
No 6203(70.6%) 868(14.0%)
Hospital admissions within 6 months prior to
last scheduled primary care appointment
Yes 1081(12.3%) 288(26.6%) <0.0001
No 7706(87.7%) 1133(14.7%)
*P values are from chi-square test.
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attended their last medical appointment. This estimate
was calculated by multiplying the difference in admis-
sion rates between the attended/no-show groups to the
total number of no-shows. Other potential costly conse-
quences include potential duplication of services such as
laboratory and radiology tests. Clearly, these costs pro-
vide impetus for the development of a multi-component
intervention that can be implemented in the clinic
setting.
The results of the study must be considered in the con-
text of its limitations. The subjects from this study were
patients enrolled in a Midwestern, urban, university-
associated primary care medical system. The demographic
characteristics of this sample are similar to those of
a national sample of patients with diabetes who attended
academic medical centers and thus, generalizability of
results may be limited to similar primary care settings [31].
The unavailability of data about the purpose of the visit
appears to be a universal problem across no-show studies.
No-showing to one visit is not an indicator of long-term
appointment keeping behavior; however, it does provide
evidence that a snapshot of no-show behavior is predictive
of future acute care utilization. Furthermore, it is not pos-
sible to describe the association between no-show and
medication compliance or glycemic control because not all
patients’ pharmacy and lab information were integrated
into the medical records database. Thus, we cannot assess
whether the association between no-show behavior and
subsequent acute care utilization could be explained by
poor glycemic control.
Table 3 Hospital admissions within 6 months after last scheduled primary care appointment
Parameter Chi- Pr > Hazard 95% Hazard
Square ChiSq Ratio Ratio
Confidence
Limits
Gender Male vs. Female 0.12 0.72 0.97 0.82–1.15
Age 31–45 vs. 18–30 0.29 0.59 0.89 0.59–1.35
46–70 vs. 18–30 0.02 0.88 0.97 0.64–1.48
≥ 71 vs. 18–30 0.007 0.93 0.98 0.62–1.55
Race Black vs. White 0.39 0.53 1.05 0.90–1.24
Other vs. White 0.27 0.61 1.18 0.63–2.23
Unknown vs. White 3.85 0.05 0.57 0.33–1.00
Insurance Medicaid vs. Commercial 21.70 <0.0001 2.21 1.58–3.09
Medicare vs. Commercial 15.19 <0.0001 1.67 1.29–2.16
Self-Pay vs. Commercial 1.85 0.17 1.31 0.89–1.91
County Tax-funded Program vs. Commercial 11.37 0.0007 1.55 1.20–2.00
Cardiovascular Yes vs. No 6.15 0.01 1.32 1.06–1.65
Nephropathy Yes vs. No 5.29 0.02 1.40 1.05–1.86
Charlson Score 2 vs. 1 3.21 0.07 1.22 0.98–1.52
≥ 3 vs. 1 29.22 <0.0001 2.05 1.58–2.66
Status at last scheduled primary care
appointment and prior hospital
admissions within 6 months
Arrived and no prior - - - -
hospital admission
Arrived and prior 117.01 <0.0001 3.84 3.01–4.90
hospital admission
No-showed and no prior hospital admission 1.84 0.17 0.83 0.63–1.09
No-showed and prior hospital admission 152.09 <0.0001 6.13 4.60–8.18
Table 4 Hospital admissions within 6 months following the last scheduled primary care appointment and whether the
primary diagnosis was for diabetes diagnoses described in prior publications as potentially preventable
Diabetes diagnosis (No) Diabetes diagnosis (Yes) Total
Attended 656(95.6%) 30(4.4%) 686(79.6%)
No-show 152(86.4%) 24(13.6%) 176(20.4%)
Total 808(93.8%) 54(6.3%) 862(100%)
* p< 0.0001 from chi-square test.
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This study does not capture ED visits and hospital
admissions that did not occur at one of the hospitals or
emergency departments associated with the three hos-
pital systems included in the RMRS. Thus, out-of-town
admissions were not included and this may have resulted
in underestimation of hospital and emergency depart-
ment utilization rates. This descriptive study from a clin-
ical setting is not designed to make statements about
causation. Specifically, we cannot address whether low
health literacy could have explained the association be-
tween no-show status and subsequent acute care
utilization. Furthermore, we were not able to describe
whether there was a recursive association between no-
show status and hospital admissions. By statistically
adjusting for hospital admissions in the prior six
months, we may have underestimated the association
between no-show behavior and subsequent hospital
admissions. Nonetheless, the findings provide strong evi-
dence that among diabetics with a recent hospital admis-
sion, those who no-show are at increased risk for a
future hospital admission.
Conclusions
The problem of no-shows has long been considered an
outpatient clinic operations problem that disrupts provi-
ders’ care plans for their chronic care patients. This study
reveals that outcomes of patients who no-show extend be-
yond the outpatient clinic setting because patients that
no-show have significantly higher rates of subsequent
acute care utilization. The results provide evidence of the
importance of proactive re-scheduling of patients who no-
show because of their vulnerability for future hospital
admissions.
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